Brain-derived neurotrophic factor in human subjects with function-altering melanocortin-4 receptor variants

International Journal of Obesity

Volumn 38, Issue 8, 2014, Pages 1068-1074

  Hohenadel, M G ^a   Thearle, M S ^a   Grice, B A ^a   Huang, H ^b   Dai, M H ^b   Tao, Y X ^b   Hunter, L A ^c   Palaguachi, G I ^c   Mou, Z ^c   Kim, R C ^c   Tsang, M M ^c   Haack, K ^d   Voruganti, V S ^d   Cole, S A ^d   Butte, N F ^e   Comuzzie, A G ^d   Muller, Y L ^a   Baier, L J ^a   Krakoff, J ^a   Knowler, W C ^a   Yanovski, J A ^c   Han, J C ^c   more..

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b AUBURN UNIVERSITY   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

BDNF; MC4R; ELISA; SNP; leptin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; MELANOCORTIN 4 RECEPTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; MC4R PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CELL SURFACE; CHILD; CONTROLLED STUDY; FEMALE; FUNCTIONAL STATUS; GAIN OF FUNCTION MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HISPANIC; HUMAN; HYPOTHALAMUS; IN VITRO STUDY; INHERITANCE; LIGAND BINDING; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR BINDING; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; AMERICAN INDIAN; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; LONGITUDINAL STUDY; METABOLISM; MUTATION; PROMOTER REGION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

PIMA; RODENTIA;

ADOLESCENT; ADULT; ARIZONA; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISPANIC AMERICANS; HUMANS; HYPOTHALAMUS; INDIANS, NORTH AMERICAN; LONGITUDINAL STUDIES; MALE; MUTATION; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 84905661985     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.221     Document Type: Article

References (39)

1. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 2003; 6: 736-742. (Pubitemid 36792889)
2. Nicholson JR, Peter JC, Lecourt AC, Barde YA, Hofbauer KG. Melanocortin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function. J Neuroendocrinol 2007; 19: 974-982. (Pubitemid 350131084)
3. Bariohay B, Roux J, Tardivel C, Trouslard J, Jean A, Lebrun B. Brain-derived neurotrophic factor/tropomyosin-related kinase receptor type B signaling is a downstream effector of the brainstem melanocortin system in food intake control. Endocrinology 2009; 150: 2646-2653.
4. Caruso C, Carniglia L, Durand D, Gonzalez PV, Scimonelli TN, Lasaga M. Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway. Mol Cell Endocrinol 2013; 348: 47-54.
5. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 2000; 19: 1290-1300. (Pubitemid 30151025)
6. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 1999; 96: 15239-15244. (Pubitemid 30019796)
7. Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci 2007; 27: 14265-14274.
8. Han JC, Liu QR, Jones M, Levinn RL, Menzie CM, Jefferson-George KS et al. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med 2008; 359: 918-927.
9. Gray J, Yeo GS, Cox JJ, Morton J, Adlam AL, Keogh JM et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 2006; 55: 3366-3371. (Pubitemid 44923594)
10. Han JC, Muehlbauer MJ, Cui HN, Newgard CB, Haqq AM. Lower brain-derived neurotrophic factor in patients with prader-willi syndrome compared to obese and lean control subjects. J Clin Endocrinol Metab 2010; 95: 3532-3536.
11. Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, Montez JM et al. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci 2003; 23: 7143-7154. (Pubitemid 36975878)
12. Stranahan AM, Arumugam TV, Mattson MP. Lowering corticosterone levels reinstates hippocampal brain-derived neurotropic factor and Trkb expression without influencing deficits in hypothalamic brain-derived neurotropic factor expression in leptin receptor-deficient mice. Neuroendocrinology 2011; 93: 58-64.
13. Nakagawa T, Ono-Kishino M, Sugaru E, Yamanaka M, Taiji M, Noguchi H. Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice. Diabetes Metab Res Rev 2002; 18: 185-191. (Pubitemid 34778381)
14. Bagnol D, Lu XY, Kaelin CB, Day HE, Ollmann M, Gantz I et al. Anatomy of qan endogenous antagonist: Relationship between Agouti-related protein and proopiomelanocortin in brain. J Neurosci 1999; 19: RC26.
15. Farooqi IS, Yeo GS, Keogh JM, Aminian S, Jebb SA, Butler G et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000; 106: 271-279. (Pubitemid 30483131)
16. Thearle MS, Muller YL, Hanson RL, Mullins M, Abdussamad M, Tran J et al. Greater impact of melanocortin-4 receptor deficiency on rates of growth and risk of type 2 diabetes during childhood compared with adulthood in Pima Indians. Diabetes 2012; 61: 250-257.
17. Xiang Z, Litherland SA, Sorensen NB, Proneth B, Wood MS, Shaw AM et al. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 2006; 45: 7277-7288. (Pubitemid 43877414)
18. Stutzmann F, Vatin V, Cauchi S, Morandi A, Jouret B, Landt O et al. Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: The two facets of a Janus obesity gene. Hum Mol Genet 2007; 16: 1837-1844. (Pubitemid 47244532)
19. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007; 50: 431-438.
20. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41: 18-24.
21. Knowler WC, Pettitt DJ, Saad MF, Charles MA, Nelson RG, Howard BV et al. Obesity in the Pima Indians: Its magnitude and relationship with diabetes. Am J Clin Nutr 1991; 53(6 Suppl): 1543S-1551S.
22. Butte NF, Cai G, Cole SA, Comuzzie AG. Viva la Familia Study: Genetic and environmental contributions to childhood obesity and its comorbidities in the Hispanic population. Am J Clin Nutr 2006; 84: 646-654. (Pubitemid 44713417)
23. Cole SA, Butte NF, Voruganti VS, Cai G, Haack K, Kent Jr. JW et al. Evidence that multiple genetic variants of MC4R play a functional role in the regulation of energy expenditure and appetite in Hispanic children. Am J Clin Nutr 2010; 91: 191-199.
24. Tao YX. The melanocortin-4 receptor: Physiology, pharmacology, and pathophysiology. Endocr Rev 2010; 31: 506-543.
25. Cai G, Cole SA, Butte N, Bacino C, Diego V, Tan K et al. A quantitative trait locus on chromosome 18q for physical activity and dietary intake in Hispanic children. Obesity (Silver Spring) 2006; 14: 1596-1604. (Pubitemid 46214827)
26. Tan K, Pogozheva ID, Yeo GS, Hadaschik D, Keogh JM, Haskell-Leuvano C et al. Functional characterization and structural modeling of obesity associated mutations in the melanocortin 4 receptor. Endocrinology 2009; 150: 114-125.
27. Tao YX, Segaloff DL. Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects. J Clin Endocrinol Metab 2005; 90: 5632-5638. (Pubitemid 41415469)
28. Xiang Z, Proneth B, Dirain ML, Litherland SA, Haskell-Luevano C. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist. Biochemistry 2010; 49: 4583-4600.
29. Sawyer TK, Sanfilippo PJ, Hruby VJ, Engel MH, Heward CB, Burnett JB et al. 4-Norleucine, 7-D-phenylalanine-Alpha-melanocyte-stimulating hormone: A highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA 1980; 77: 5754-5758. (Pubitemid 11206397)
30. Tao YX, Segaloff DL. Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 2003; 144: 4544-4551. (Pubitemid 37204854)
31. Comuzzie AG, Cole SA, Laston SL, Voruganti VS, Haack K, Gibbs RA et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One 2012; 7: E51954.
32. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z et al. 2000 CDC Growth Charts for the United States: Methods and development. Vital Health Stat 2002; 11: 1-190.
33. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44: 45-60. (Pubitemid 20177198)
34. Gaunt TR, Rodriguez S, Day IN. Cubic exact solutions for the estimation of pairwise haplotype frequencies: Implications for linkage disequilibrium analyses and a web tool CubeX. BMC Bioinformatics 2007; 8: 428.
35. Katoh-Semba R, Wakako R, Komori T, Shigemi H, Miyazaki N, Ito H et al. Age-related changes in BDNF protein levels in human serum: Differences between autism cases and normal controls. Int J Dev Neurosci 2007; 25: 367-372. (Pubitemid 350051327)
36. Webster MJ, Herman MM, Kleinman JE, Shannon Weickert C. BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr Patterns 2006; 6: 941-951. (Pubitemid 44309446)
37. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269. (Pubitemid 36144114)
38. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J et al. Brainderived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002; 87: 728-734. (Pubitemid 34302963)
39. El-Gharbawy AH, Adler-Wailes DC, Mirch MC, Theim KR, Ranzenhofer L, Tanofsky-Kraff M et al. Serum brain-derived neurotrophic factor concentrations in lean and overweight children and adolescents. J Clin Endocrinol Metab 2006; 91: 3548-3552. . (Pubitemid 44402136)